Detalles de la búsqueda
1.
An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer.
Cancer Control
; 31: 10732748241250189, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797949
2.
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.
Cancer Immunol Immunother
; 72(11): 3461-3474, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528320
3.
Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment.
Cancer Immunol Immunother
; 70(9): 2439-2451, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818636
4.
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.
BMC Cancer
; 20(1): 445, 2020 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32429929
5.
An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.
Cancer Immunol Immunother
; 68(8): 1379-1389, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31338557
6.
Traumatic brain injury-induced neuronal damage in the somatosensory cortex causes formation of rod-shaped microglia that promote astrogliosis and persistent neuroinflammation.
Glia
; 66(12): 2719-2736, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30378170
7.
Cognitive deficits develop 1month after diffuse brain injury and are exaggerated by microglia-associated reactivity to peripheral immune challenge.
Brain Behav Immun
; 54: 95-109, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26774527
8.
Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials.
Cancer Res Commun
; 4(1): 81-91, 2024 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108458
9.
A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms.
Clin Cancer Res
; 29(4): 731-741, 2023 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36255391
10.
Single-cell RNA sequencing identifies a population of human liver-type ILC1s.
Cell Rep
; 42(1): 111937, 2023 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36640314
11.
Observations on the use of Bruton's tyrosine kinase inhibitors in SAR-CoV-2 and cancer.
J Hematol Oncol
; 14(1): 15, 2021 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33441177
12.
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma.
Front Immunol
; 12: 740890, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34712230
13.
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.
Drug Des Devel Ther
; 14: 1693-1704, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32440095
14.
Reciprocal Signaling between Myeloid Derived Suppressor and Tumor Cells Enhances Cellular Motility and is Mediated by Structural Cues in the Microenvironment.
Adv Biosyst
; 4(6): e2000049, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32419350
15.
Guided migration analyses at the single-clone level uncover cellular targets of interest in tumor-associated myeloid-derived suppressor cell populations.
Sci Rep
; 10(1): 1189, 2020 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31988310
16.
CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
J Immunother Cancer
; 8(1)2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32581043
17.
Evidence for interaction of the NLRP3 inflammasome and Bruton's tyrosine kinase in tumor-associated macrophages: implications for myeloid cell production of interleukin-1beta.
Oncoimmunology
; 8(11): 1659704, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31646085
18.
Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro.
J Immunother Cancer
; 7(1): 140, 2019 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31138333
19.
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 25(16): 4955-4965, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31142501
20.
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.
Clin Cancer Res
; 24(8): 1891-1904, 2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29363526